Low HDL on Anabolic Steroids: Why It Drops and What It Signals
Suppressed HDL is one of the most consistent effects of anabolic steroids. The degree tracks the compound and route — and it's a marker worth respecting.
The most reliable lipid change on AAS
Anabolic steroids upregulate hepatic lipase, which clears HDL particles faster. The result is lower HDL — sometimes dramatically lower, especially with oral compounds.
Unlike hematocrit (an expected, manageable rise), low HDL is a genuine cardiovascular-risk signal that doesn't get a 'context' pass just because it's expected.
Read it with ApoB
HDL alone is an incomplete picture. ApoB counts atherogenic particles and is the better single marker of cardiovascular risk; many AAS raise ApoB while suppressing HDL.
Together they frame the real lipid cost of a protocol — which is why both belong on every panel.
In enhanced context
- Oral compounds suppress HDL harder than injectables; route and compound choice dominate the effect.
- An HDL near or below 0.5 mmol/L is a meaningful signal worth discussing with a clinician, not a number to normalize.
- Cardio, omega-3s, and protocol choices are common discussion points — decisions belong with a physician.
FAQ
Anabolic steroids increase hepatic lipase activity, which clears HDL faster. Oral compounds have the strongest effect. The drop is expected but still represents real cardiovascular risk worth monitoring.
Persistently low HDL raises cardiovascular risk. Read alongside ApoB and the rest of the lipid panel, and discuss management with a physician — it's not a number to simply accept.
Related: ApoB · LDL Cholesterol · Triglycerides
Educational information only — not medical advice, diagnosis, or treatment, and not a recommendation about any medication or compound. Reference ranges are context estimates pending clinical review. Consult a physician about your results.